Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Researchers feature successful diabetes interventions in drive to end global health disparities

Two people casually talking to one another.

Xanadu Roque, a Project Extension for Community Health Outcomes, or ECHO™️, Diabetes Support Coach, works with a mentee. Led by UF and Stanford University, the Project ECHO Diabetes program empowers primary care providers to deliver best-practice diabetes care to their patients who are underserved.

Worldwide rates of diabetes are expected to nearly triple over the next two decades to an estimated 1.3 billion people with the condition by 2050.

To address the rapidly expanding disease crisis, a group of experts led by Ashby Walker, Ph.D., an assistant professor in the department of health services research, management and policy at the University of Florida College of Public Health and Health Professions, part of UF Health, have authored an article that highlights several international diabetes programs that combat well-documented health disparities in diabetes and lead to positive health outcomes for people living with the disease.

The article is part of a special three-part series on global inequity in diabetes care published June 23 in the journal The Lancet.

The article by Walker and colleagues notes that approximately three-quarters of people with diabetes live in low- or middle-income countries and they experience a large discrepancy in healthy life-years lost to diabetes, compared with people with diabetes in high-income countries.

The authors argue that to address diabetes disparities, interventions need to recognize individual patients within a broader social context that considers factors at multiple levels, including the clinical practice environment and health insurance coverage, as well as broader societal issues, such as stigma related to the disease.

Their article features seven diabetes care programs across four continents that have targeted aspects of social context related to root causes of inequity, said Walker, the chair of the American Diabetes Association’s National Health Disparities Committee and the director for health equity initiatives at the UF Diabetes Institute, also part of UF Health.


Dr. Ashby Walker (right) with co-author, Dr. Shivani Agarwal of the Albert Einstein College of Medicine and Montefiore Medical Center, after presenting at a Lancet symposium held this week at the American Diabetes Association’s 83rd Scientific Sessions.
Dr. Ashby Walker (right) with co-author, Dr. Shivani Agarwal of the Albert Einstein College of Medicine and Montefiore Medical Center, after presenting at a Lancet symposium held this week at the American Diabetes Association’s 83rd Scientific Sessions.

“The programs also share a common theme of having stakeholder-driven initiatives,” Walker said, “they rely on multisector collaboration and many target policy-level change as part of their aims.”

In Milwaukee, efforts have focused on addressing food and financial insecurity, increasing community capacity through partnership building and changing policies that perpetuate racism.

In five sub-Saharan African countries, the Diabetes CarePak program targets diabetes care at the individual, community and policy levels. The program offers critical diabetes supplies as well as education and outreach with input from members of underrepresented groups. Food product labels provide nutritional information to promote healthy food choices.

“We cannot simply focus on individual-level solutions, but rather, we must approach the individual within a larger social and structural context,” Walker said. “Policy-level changes that ensure access to insulin as well as to technologies like continuous glucose monitors must be part of large-scale efforts to promote equity in diabetes. The cost of drugs like insulin and new technologies is a real barrier for medically underserved communities.”

A bill passed recently in Florida will make the state’s Medicaid beneficiaries eligible for continuous glucose monitors with a provider’s prescription. Without insurance, the monitors cost patients about $1,700 a year.

“This will have tremendous dividends for improving health outcomes and reducing diabetes-related costs associated with complications,” Walker said.

About the author

Jill Pease
Communications Director, College of Public Health and Health Professions

For the media

Media contact

Matt Walker
Media Relations Coordinator
mwal0013@shands.ufl.edu (352) 265-8395